Clinical Trial Update: Efficacy of Macrolide Immunomodulation in Severe Sepsis. [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating macrolide-based immunomodulation in severe sepsis was terminated. The update references efficacy assessment within the conte…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Sepsis
• Systemic Inflammatory Response Syndrome

Drugs mentioned

• Macrolide (macrolide antibiotic)

Snippet

Sponsor: VA Office of Research and Development | Conditions: Systemic Inflammatory Response Syndrome | Phase 2 | Status: TERMINATED